These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14716901)

  • 1. [Allogeneic bone marrow transplantation].
    Sengeløv H; Nielsen B; Vindeløv LL
    Ugeskr Laeger; 2003 Dec; 165(50):4844-6. PubMed ID: 14716901
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow allograft. Part 1: principles--modalities and indications].
    Ladeb S; Abdelkefi A; Ben Othman T; Torjmene L; Ben Abdeladhim A
    Tunis Med; 1999 Apr; 77(4):185-90. PubMed ID: 10392016
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
    Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
    Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation in a child with severe aplastic anemia and hemophilia A.
    Ostronoff M; Ostronoff F; Campos G; Arruda S; Vaz C; Florencio R; Calixto R; Souto Maior AP; Sucupira A; Domingues M; Tagliari C
    Bone Marrow Transplant; 2006 Mar; 37(6):627-8. PubMed ID: 16444275
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.
    Orciuolo E; Azzarà A; Bandini G; Galimberti S; Bonifazi F; Fazzi R; Petrini M
    Bone Marrow Transplant; 2004 Apr; 33(8):859-61. PubMed ID: 14743194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
    Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
    Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in Fanconi anemia.
    Gluckman E
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S33-5. PubMed ID: 8971405
    [No Abstract]   [Full Text] [Related]  

  • 11. Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Slavin S
    Transplant Proc; 2007 Apr; 39(3):678-84. PubMed ID: 17445572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic eosinophilic pneumonia in a patient treated with allogeneic bone marrow transplantation].
    Brunet S; Muñiz-Díaz E; Baiget M
    Med Clin (Barc); 1994 Nov; 103(17):677. PubMed ID: 7808070
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
    Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
    Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors.
    Schattenberg A; van der Meer A; Preijers F; Schaap N; Rinkes M; van der Maazen R; Allebes W; Joosten I; De Witte T
    Bone Marrow Transplant; 2004 Jun; 33(11):1115-21. PubMed ID: 15064694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.
    Sato N; Furukawa T; Kuroha T; Hashimoto S; Masuko M; Takahashi H; Yano T; Abe T; Fuse I; Koike T; Kishi K; Aizawa Y
    Bone Marrow Transplant; 2004 Aug; 34(4):299-303. PubMed ID: 15195078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
    O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
    Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
    Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH
    Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.